RSS   Newsletter   Contact   Advertise with us
Post Online Media

InVivo Therapeutics appoints Christopher McNulty as CFO

InVivo TherapeuticsInVivo Therapeutics Holdings announced the appointment of Christopher McNulty as chief financial officer.

Prior to being appointed Chief Financial Officer, Mr. McNulty served at InVivo as Senior Vice President, Business Development and Investor Relations, where he was responsible for evaluating all partnerships and licensing opportunities.

READ MORE InVivo Therapeutics appoints Jay Blackington as vice president

In addition to his responsibilities in business development, Mr. McNulty played a key role in the company’s financings, including a follow-on offering and registered direct financing.

Prior to joining InVivo, Mr. McNulty served as Senior Director, Business Development of Repligen Corporation.

At Repligen, he led all aspects of the company’s acquisition of Novozymes Sweden, including financial modeling, diligence, strategy, and negotiation.

Previously, Mr. McNulty served as Director, Corporate Development at Seventh Sense Biosystems, where he was responsible for corporate strategy, market evaluation, and business development.

Mr. McNulty received his B.S. and M.Eng. degrees in electrical engineering and computer science from MIT, and his M.B.A. from Harvard Business School.




What to read next



 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy